David Osselton

Professor David Osselton

  • 01202 961723
  • dosselton at bournemouth dot ac dot uk
  • Head of Academic Group: FBS
  • Christchurch House C239, Talbot Campus, Fern Barrow, Poole, BH12 5BB
Back to top

Biography

Prof Osselton joined the staff of Bournemouth University (BU) in January 2007 to take up an appointment as Director of the Centre for Forensic Sciences at Bournemouth University.

After completing his PhD in Biochemistry he joined the Home Office Forensic Science Service (FSS) in 1974 to carry out toxicology research at the Central Research Establishment, Aldermaston. He gained casework experience as Senior Toxicologist working at the Home Office Forensic Science laboratories in Nottingham and Huntingdon before returning to Aldermaston in 1984 as Head of Research in Alcohol, Drugs and Toxicology. In 1991 he was appointed Head of Toxicology for the Forensic Science Service where he was responsible for developing toxicology services in addition to undertaking casework and providing advice to Government departments on drug testing. Prof. Osselton has been involved in a number of high profile cases for the defence and prosecution both in the UK and overseas. He is internationally known for his research interests in toxicology and lectures widely at conferences around the world as a plenary and keynote speaker...

more

Favourites

  • Rees, K.A., Pounder, D.J. and Osselton, M.D., 2013. Distribution of opiates in femoral blood and vitreous humour in heroin/morphine-related deaths. Forensic Science International, 226 (1-3), 152-159.
  • Rees, K.A., Pounder, D.J. and Osselton, M.D., 2013. Distribution of opiates in femoral blood and vitreous humour in heroin/morphine-related deaths. Forensic Sci Int, 226 (1-3), 152-159.
  • Rees, K.A., Seulin, S., Yonamine, M., Leyton, V., Munoz, D.R., Gianvecchio, V.A.P., Pounder, D.J. and Osselton, M.D., 2013. Analysis of skeletal muscle has potential value in the assessment of cocaine-related deaths. Forensic Sci Int, 226 (1-3), 46-53.
  • McLaughlin, P., Pounder, D., Maskell, P. and Osselton, D., 2013. Real-time near-body drug screening during autopsy I: Use of the Randox biochip drugs of abuse DOA i and DOA II immunoassays. Forensic Toxicology, 31 (1), 113-118.

Journal Articles

  • Mactier, H., McLaughlin, P., Gillis, C. and Osselton, M.D., 2017. Variations in Infant CYP2B6 Genotype Associated with the Need for Pharmacological Treatment for Neonatal Abstinence Syndrome in Infants of Methadone-Maintained Opioid-Dependent Mothers. AMERICAN JOURNAL OF PERINATOLOGY, 34 (9), 918-921.
  • Assi, S., Gulyamova, N., Kneller, P. and Osselton, D., 2017. The effects and toxicity of cathinones from the users' perspectives: A qualitative study. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 32 (3).
  • Assi, S., Gulyamova, N., Ibrahim, K., Kneller, P. and Osselton, D., 2017. Profile, effects, and toxicity of novel psychoactive substances: A systematic review of quantitative studies. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 32 (3).
  • McLaughlin, P., Mactier, H., Gillis, C., Hickish, T., Parker, A., Liang, W.J. and Osselton, M.D., 2017. Increased DNA Methylation of ABCB1, CYP2D6, and OPRM1 Genes in Newborn Infants of Methadone-Maintained Opioid-Dependent Mothers. Journal of Pediatrics.
  • Assi, S., Osselton, D. and Wallis, B., 2016. The evaluation of dual laser handheld raman spectroscopy for identifying novel psychoactive substances. American Pharmaceutical Review, 19 (6).
  • Assi, S., Thomas, J., Haffar, M. and Osselton, D., 2016. Exploring Consumer and Patient Knowledge, Behavior, and Attitude Toward Medicinal and Lifestyle Products Purchased From the Internet: A Web-Based Survey. JMIR public health and surveillance, 2 (2), e34.
  • Assi, S., Kneller, P. and Osselton, M., 2014. Identifying Organic Impurities in Counterfeit and Illicit Tobacco Using Portable ATR-FT-IR Spectroscopy. Raman Technology for Today's Spectroscopists, 40-50.
  • Reichardt, E.M., Baldwin, D. and Osselton, M.D., 2013. Effects of oral fluid contamination on two oral fluid testing systems. J Anal Toxicol, 37 (4), 246-249.
  • Rees, K.A., Pounder, D.J. and Osselton, M.D., 2013. Distribution of opiates in femoral blood and vitreous humour in heroin/morphine-related deaths. Forensic Science International, 226 (1-3), 152-159.
  • Rees, K.A., Seulin, S., Yonamine, M., Leyton, V., Munoz, D.R., Gianvecchio, V.A.P., Pounder, D.J. and Osselton, M.D., 2013. Analysis of skeletal muscle has potential value in the assessment of cocaine-related deaths. Forensic Science International, 226 (1-3), 46-53.
  • Rees, K.A., Pounder, D.J. and Osselton, M.D., 2013. Distribution of opiates in femoral blood and vitreous humour in heroin/morphine-related deaths. Forensic Sci Int, 226 (1-3), 152-159.
  • Rees, K.A., Seulin, S., Yonamine, M., Leyton, V., Munoz, D.R., Gianvecchio, V.A.P., Pounder, D.J. and Osselton, M.D., 2013. Analysis of skeletal muscle has potential value in the assessment of cocaine-related deaths. Forensic Sci Int, 226 (1-3), 46-53.
  • Dussault, M.C., Smith, M.J. and Osselton, M., 2013. Blast injury and the Human skeleton: An important emerging aspect of conflict related trauma. Journal of Forensic Sciences, in press.
  • McLaughlin, P., Pounder, D., Maskell, P. and Osselton, D., 2013. Real-time near-body drug screening during autopsy I: Use of the Randox biochip drugs of abuse DOA i and DOA II immunoassays. Forensic Toxicology, 31 (1), 113-118.
  • de Almeida, R.M., de Lima, D.S., Seulin, S.C., Leyton, V., Pasqualucci, C.A., Muñoz, D.R., Osselton, M.D. and Yonamine, M., 2012. Hollow-fiber liquid-phase microextraction and gas chromatography-mass spectrometry of barbiturates in whole blood samples. J Sep Sci, 35 (23), 3361-3368.
  • Chatterton, C. and Osselton, M., 2012. Toxicology Analysis for Pathologists: A Review of the Available Techniques and Technologies, Including Recommendations for Best Practice. Academic Forensic Pathology, 2 (3), 216-221.
  • Rees, K.A., Jones, N.S., McLaughlin, P.A., Seulin, S., Leyton, V., Yonamine, M. and Osselton, M.D., 2012. The effect of sodium fluoride preservative and storage temperature on the stability of cocaine in horse blood, sheep vitreous and deer muscle. FORENSIC SCIENCE INTERNATIONAL, 217 (1-3), 182-188.
  • Rees, K.A., Jones, N.S., McLaughlin, P.A. and Osselton, M.D., 2012. The effect of sodium fluoride preservative and storage temperature on the stability of 6-acetylmorphine in horse blood, sheep vitreous and deer muscle. Forensic Sci Int, 217 (1-3), 189-195.
  • McLaughlin, P., Pounder, D., Maskell, P. and Osselton, D., 2012. Real-time near-body drug screening during autopsy I: use of the Randox biochip drugs of abuse DOA I and DOA II immunoassays. Forensic Toxicology, 1-6.
  • Burnand, D., Osselton, M., Hubbard, P.C., Muller, C.T., Griffiths, S.W., Andreou, D., Canario, A.V.M. and Gozlan, R.E., 2012. Chemically-mediated sexual display postures in pre-ovulatory female topmouth gudgeon Pseudorasbora parva. Behaviour brill, 149, 1003-1018.
  • Smith, M., Kneller, P., Elliott, D., Young, C., Manley, H. and Osselton, D., 2012. Multidisciplinary analysis of a mummified cranium claimed to be that of a medieval execution victim. Archaeological and Anthropological Sciences, 4, 75-89.
  • Bunten, H., Liang, W.-J., Pounder, D., Seneviratne, C. and Osselton, D.M., 2011. CYP2B6 and OPRM1 gene variations predict methadone-related deaths. Addiction Biology, 16, 142-144.
  • Bunten, H., Liang, W.-J., Pounder, D. and Osselton, D.M., 2011. Interindividual variability in the prevalence of OPRM1 and CYP2B6 gene variations may identify drug-susceptible populations. Journal of Analytical Toxicology, 35, 431-437.
  • Sanches, L., Seulin, S., Leyton, V., Paranhos, B., Pasqualuccib, C., Munoz, D., Osselton, D.M. and Yonamine, M., 2011. Determination of opiates in whole blood and vitreous humor: a study of the matrix effect and an experimental design to optimise conditions for the enzymatic hydrolysis of glucuronides. Journal of Analytical Toxicology.
  • Rees, K.-A., McLaughlin, P. and Osselton, D.M., 2011. Validation of a Gas Chromatography–Ion Trap-Tandem Mass Spectrometry Assay for the Simultaneous Quantification of Cocaine, Benzoylecgonine, Cocaethylene, Morphine, Codeine and 6-Acetylmorphine in Aqueous Solution, Blood and Skeletal Muscle Tissue. Journal of Analytical Toxicology.
  • Rees, K.-A., Jones, N., McLaughlin, P., Seulin, S., Leyton, V., Yonamine, M. and Osselton, D.M., 2011. The Effect of Storage Temperature and Sodium Fluoride Preservative on the Stability of Cocaine in Horse Blood, Sheep Vitreous and Deer Muscle. Forensic Science International.
  • Bunten, H., Liang, W.-J., Pounder, D. and Osselton, D.M., 2010. OPRM1 and CYP2B6 gene variants as risk factors in methadone-related deaths. Clinical Pharmacology and Therapeutics, 88, 383-389.
  • Cooper, G., Paterson, S. and Osselton, D.M., 2010. The United Kingdom and Ireland association of Forensic Toxicologists Forensic Toxicology Laboratory Guidelines (2010). Science and Justice, 50, 166-176.
  • Osselton, M.D., 2010. United Kingdom & Ireland Association of Forensic Toxicologists - Guest Editorial. Science and Justice, 50, 165.
  • Parkin, M.C., Turfus, S.C., Smith, N.W., Halket, J.M., Braithwaite, R.A., Elliott, S.P., Osselton, D.M., Cowan, D.A. and Kicman, A.T., 2008. Detection of Ketamine and its Metabolites in Urine by Ultra High Pressure Liquid Chromatography–Tandem Mass Spectrometry. Journal of Chromatography B, 876, 137-142.
  • Smith, R.M., Westlake, J.P., Gill, R. and Osselton, M.D., 1992. Retention reproducibility of basic drugs in high-performance liquid chromatography on a silica column with a methanol-high-pH buffer eluent. Changes in selectivity with the age of the stationary phase. J Chromatogr, 592 (1-2), 85-92.
  • Osselton, M.D., 1992. Analytical forensic toxicology. Arch Toxicol Suppl, 15, 259-267.
  • Gomm, P.J., Osselton, M.D., Broster, C.G., Johnson, N.M. and Upton, K., 1991. The effect of salbutamol on breath alcohol testing in asthmatics. Med Sci Law, 31 (3), 226-228.
  • Gomm, P.J., Osselton, M.D., Broster, C.G., Johnson, N.M. and Upton, K., 1991. Study into the ability of patients with impaired lung function to use breath alcohol testing devices. Med Sci Law, 31 (3), 221-225.
  • Gill, R., Osselton, M.D., Broad, J.E. and Ramsey, J.D., 1991. The response of evidential breath alcohol testing instruments with subjects exposed to organic solvents and gases. III. White spirit exposure during domestic painting. Med Sci Law, 31 (3), 214-220.
  • Gill, R., Warner, H.E., Broster, C.G., Osselton, M.D., Ramsey, J.D., Wilson, H.K. and Wilcox, A.H., 1991. The response of evidential breath alcohol testing instruments with subjects exposed to organic solvents and gases. II. White spirit and nonane. Med Sci Law, 31 (3), 201-213.
  • Gill, R., Hatchett, S.E., Broster, C.G., Osselton, M.D., Ramsey, J.D., Wilson, H.K. and Wilcox, A.H., 1991. The response of evidential breath alcohol testing instruments with subjects exposed to organic solvents and gases. I. Toluene, 1,1,1-trichloroethane and butane. Med Sci Law, 31 (3), 187-200.
  • Weston, S.I., Japp, M., Partridge, J. and Osselton, M.D., 1991. Collection of analytical data for benzodiazepines and benzophenones. Appendix. Journal of Chromatography A, 538 (2), 277-284.
  • Osselton, M.D., Japp, M., Weston, S.I., Mather, E.A., Spiehler, V., Barlow, R. and Moore, A., 1990. Whole blood quality assurance control samples for forensic toxicology. J Anal Toxicol, 14 (5), 318-319.
  • Gomm, P.J., Weston, S.I. and Osselton, M.D., 1990. The effect of respiratory aerosol inhalers and nasal sprays on breath alcohol testing devices used in Great Britain. Med Sci Law, 30 (3), 203-206.
  • Smith, R.M., Gill, R. and Osselton, M.D., 1990. Erratum: A reassessment of 'Use of corrected retention indices based on 1-nitroalkane and alkylarylketone scales for HPLC identification of basic drugs' (J. Anal. Toxicol. 13(6): 375 (1989)). Journal of Analytical Toxicology, 14 (1).
  • Smith, R.M., Westlake, J.P., Gill, R. and David Osselton, M., 1990. Retention reproducibility of basic drugs in high-performance liquid chromatography on a silica column with a methanol-high-pH buffer eluent. Effect of operating conditions on separations using an organic buffer. Journal of Chromatography A, 514 (C), 97-109.
  • Smith, R.M., Gill, R. and Osselton, M.D., 1989. A reassessment of 'use of corrected retention indices based on 1-nitroalkane and alkylarylketone scales for HPLC identification of basic drugs'. J Anal Toxicol, 13 (6), 375-377.
  • Hughes, R.J. and Osselton, M.D., 1989. Comparison of methods for the analysis of tricyclic antidepressants in small whole blood samples. J Anal Toxicol, 13 (2), 77-83.
  • Gill, R., Osselton, M.D. and Smith, R.M., 1989. International collaborative study of the retention reproducibility of basic drugs in high-performance liquid chromatography on a silica column with a methanol-ammonium nitrate eluent. J Pharm Biomed Anal, 7 (4), 447-457.
  • Smith, R.M., Hurdley, T.G., Westlake, J.P., Gill, R. and Osselton, M.D., 1988. Retention reproducibility of basic drugs in high-performance liquid chromatography on a silica column with a methanol-ammonium nitrate eluent. Batch-to-batch reproducibility of the stationary phase. J Chromatogr, 455, 77-93.
  • Spiehler, V., Spiehler, E. and Osselton, M.D., 1988. Application of expert systems analysis to interpretation of fatal cases involving amitriptyline. J Anal Toxicol, 12 (4), 216-224.
  • Japp, M., Garthwaite, K., Geeson, A.V. and Osselton, M.D., 1988. Collection of analytical data for benzodiazepines and benzophenones. J Chromatogr, 439 (2), 317-339.
  • Gill, R., Hatchett, S.E., Osselton, M.D., Wilson, H.K. and Ramsey, J.D., 1988. Sample handling and storage for the quantitative analysis of volatile compounds in blood: the determination of toluene by headspace gas chromatography. J Anal Toxicol, 12 (3), 141-146.
  • Japp, M., Gill, R. and Osselton, M.D., 1987. Comparison of drug retention indices determined on packed, wide bore capillary and narrow bore capillary columns. Journal of Forensic Sciences, 32 (6), 1574-1586.
  • Smith, R.M., Hurdley, T.G., Gill, R. and Osselton, M.D., 1987. Retention reproducibility of basic drugs in high-performance liquid chromatography on a silica column with a methanol-ammonium nitrate eluent. The effect of the mobile phase and the operating conditions. J Chromatogr, 398, 73-87.
  • Gill, R., Osselton, M.D., Smith, R.M. and Hurdley, T.G., 1987. Retention reproducibility of basic drugs in high-performance liquid chromatography on a silica column with a methanol-ammonium nitrate eluent. Interlaboratory collaborative study. J Chromatogr, 386, 65-77.
  • Foxwell, J.D. et al., 1987. Short papers in pharmaceutical analysis. Analytical Proceedings, 24 (6), 182-195.
  • Japp, M., Gill, R. and Osselton, M.D., 1987. The separation of lysergide (LSD) from related ergot alkaloids and its identification in forensic science casework samples. Journal of Forensic Sciences, 32 (4), 933-940.
  • Osselton, M.D. and Snelling, R.D., 1986. Chromatographic identification of pesticides. J Chromatogr, 368 (2), 265-271.
  • Osselton, M.D., Blackmore, R.C., King, L.A. and Moffat, A.C., 1984. Poisoning-associated deaths for England and Wales between 1973 and 1980. Hum Toxicol, 3 (3), 201-221.
  • Locke, J., Carpenter, R. and Osselton, M.D., 1981. Mineral content of reagents used in subtilisin assays. Med Sci Law, 21 (2), 123-124.
  • Osselton, M.D., Hammond, M.D. and Moffat, A.C., 1980. Distribution of drugs and toxic chemicals in blood. J Forensic Sci Soc, 20 (3), 187-193.
  • Osselton, M.D., Hammond, M.D. and Moffat, A.C., 1980. Statistics for deaths from poisoning 1973 to 1975 for England and Wales. J Forensic Sci Soc, 20 (2), 125-134.
  • Ramsey, J.D., Lee, T.D., Osselton, M.D. and Moffat, A.C., 1980. Gas--liquid chromatographic retention indices of 296 non-drug substances on SE-30 or OV-1 likely to be encountered in toxicological analyses. J Chromatogr, 184 (2), 185-206.
  • Hammond, M.D., Osselton, M.D. and Moffat, A.C., 1979. The extraction and analysis of benzodiazepine drugs in bloodstains. J Forensic Sci Soc, 19 (3), 193-198.
  • Dunnett, N., Ashton, P.G. and Osselton, M.D., 1979. The use of enzymes as an aid to release drugs from soil following the exhumation of a skeleton. Vet Hum Toxicol, 21 Suppl, 199-201.
  • Osselton, M.D., 1979. The use of proteolytic enzymes to release high levels of drugs from biological materials submitted for toxicological analysis. Vet Hum Toxicol, 21 Suppl, 177-179.
  • Osselton, M.D., Shaw, I.C. and Stevens, H.M., 1978. Enzymic digestion of liver tissue to release barbiturates, salicylic acid and other acidic compounds in cases of human poisoning. Analyst, 103 (1232), 1160-1164.
  • Osselton, M.D., 1978. The release of basic drugs by the enzymic digestion of tissues in cases of poisoning. J Forensic Sci Soc, 17 (2-3), 189-194.
  • Linnett, P.E., Mitchell, A.D., Osselton, M.D., Mulheirn, L.J. and Beechey, R.B., 1978. Citreoviridin, a specific inhibitor of the mitochondiral adenosine triphosphatase. Biochem J, 170 (3), 503-510.
  • Osselton, M.D., Hammond, M.D. and Twitchett, P.J., 1977. The extraction and analysis of benzodiazepines in tissues by enzymic digestion and high-performance liquid chromatography. J Pharm Pharmacol, 29 (8), 460-462.
  • Osselton, M.D., 1976. Interaction between methadone and ether peroxides to produce 1,5-dimethyl-3, 3-diphenyl-2-ethylidene-pyrrolidine the major cyclic metabolite of methadone. J Forensic Sci Soc, 16 (4), 299-303.
  • Mulheirn, L.J., Beechey, R.B., Leworthy, D.P. and Osselton, M.D., 1974. Aurovertin B, a metabolite of Calcarisporium arbuscula. Journal of the Chemical Society, Chemical Communications, 874-876.

Books

  • Pounder, D.J., 2015. Encyclopedia of Forensic and Legal Medicine, Autopsy Findings: Postmortem Drug Sampling and Redistribution. Elsevier.
  • Clarke's Analysis of Drugs and Poisons. 4th ed.. London: Royal Pharmaceutical Society.
  • Jickells, S. and Negrusz, A., 2008. Clarke's Analytical Forensic Toxicology. London: Pharmaceutical Press.
  • Moffat, A.C., Osselton, D.M. and Widdop, B., 2004. Clarke’s Analysis of Drugs and Poisons: in pharmaceuticals, body fluids, and postmortem material. London: Pharmaceutical Press.
  • Moffat, A.C., Osselton, M.D., Widdop, B. and Clarke, E.G.C., 2004. Clarke's analysis of drugs and poisons. Pharmaceutical Pr.

Chapters

  • Osselton, M., 2016. Urinalysis: The detection of Drugs in Urine. In: Wolff, K., ed. Detection of Drug Misuse. Royal Society of Chemistry.
  • Logan, B.K. and Osselton, D.M., 2011. Driving under the Influence of Drugs. Clarke's Analysis of Drugs and Poisons. London: Pharmaceutical Press, 115-126.
  • Osselton, D.M., Moffat, A.C. and Widdop, B., 2011. Forensic Toxicology. Clarke's Analysis of Drugs and Poisons. 4th ed.. London: Royal Pharmaceutical Society.
  • Osselton, D.M., 2011. Drug Facilitated Sexual Assault. Clarke's Analysis of Drugs and Poisons. 4th ed.. London: Royal Pharmaceutical Society.
  • Cowan, D.A., Osselton, D.M. and Robinson, S., 2007. Drug Testing. In: Nutt, D.J., Robbins, T.W., Stimson, G.V., Ince, M. and Jackson, A., eds. Drugs and the Future, Brain Science, Addiction and Society. Burlington, USA: Elsevier/Academic Press, 315-335.
  • Osselton, D.M., 2004. Forensic Toxicology. In: Moffat, A.C., Ossleton, D.M. and Widdop, B., eds. Clarke’s Analysis of Drugs and Poisons:in pharmaceuticals, body fluids, and postmortem material. Pharmaceutical Press, 80-93.
  • Osselton, D.M., 2000. Drugs and Drugs of Abuse in Post-Mortem Blood. In: Siegel, J.A., Saukko, P.J. and Knupfer, G.C., eds. Encyclopedia of Forensic Sciences. San Diego, USA: Academic Press, 646-6500.
  • Osselton, M.D., Ramsey, J. and Wooley, J., 1992. Interactive Knowledge Based Systems in Forensic Toxicology. In: Oliver, J., ed. Forensic Toxicology; Proc 26th International Meeting of TIAFT. EAst Kilbride: Courier intl, 81-84.

Conferences

  • Zorba, J., Whittington, A.E. and Osselton, M.D., 2015. Observations on the Effect of Benzylpiperazine on the Larval Development Rate of Calliphora vomitoria and its Implications on the Estimation of Post Mortem Intervals. In: The UK and Ireland Association of Forensic Toxicologists (UKIAFT) Annual Meeting and Conference 10-11 September 2015 Bournemouth.
  • Osselton, M., Reichardt, E.M. and Baldwin, D., 2014. Application of an Immunohistochemical staining Method to detect and Visualise the Presence of Opiates in Mice Following Peritoneal Injection of Morphine. In: SOFT 2014 20-24 October 2014 Grand Rapids, Michigan, USA.
  • Osselton, M., 2013. Recent Developments relating to Driving Under the Influence of Drugs and Roadside Testing in the United Kingdom. In: Drink, Drugs, Sleep and Transport 19 October 2013 Royal Society of Medicine.
  • Osselton, M.D., 2013. Tackling the Challenges of Drugs in Society. In: Partnerships in safety: Building Safe and Just Societies 21 July-1 August 2013 Belfast.
  • Reichardt,, E.M., Baldwin, D. and Osselton, M.D., 2013. Histochemical Staining as a Method for Demonstrating the Presence of Heroin and Cocaine in Oral Tissue. In: United Kindom and Ireland Association of Forensic Toxicologists 2013 15-16 August 2013 Dublin.
  • Osselton, M.D., 2013. Recent Developments relating to Driving Under the Influence of Drugs and Roadside Drug Testing in the United Kingdom. In: United Kingdom and Ireland Association of Forensic Toxicologists 2013 15-16 August 2013 Dublin.
  • Osselton, M., 2013. Drugs and Driving. In: 50th Aniversary Meeting of The International Association of Forensic Toxicologists (TIAFT) 26-27 April 2013 London.
  • Reichardt, E., Baldwin, D. and Osselton, D.M., 2011. Concentration of Cocaine and Cocaine Metabolites after Drinking coca Tea. In: 2011 Joint Meeting of Society of Forensic Toxicologists(SOFT) & International Association of Forensic Toxicologists (TIAFT) 25-30 September 2011 San Fransisco,CA, USA.
  • Osselton, D.M., 2011. Pharmacogenomics Applied to Forensic Sciences. In: XVII Brazilian Congress of Toxicology 22-25 June 2011 Ribeirao Preto, Brazil.
  • Osselton, D.M., 2011. Forensic Toxicology. In: XVII Brazilian Congress of Toxicology 22-25 June 2011 Ribeirao Preto, Brazil.
  • Osselton, D.M., 2011. Interpretation in Forensic Toxicology. In: Royal Pharmaceutical Society International Clarke Conference on Analytical Toxicology 2 May 2011 London.
  • McLaughlin, P., Pounder, D. and Osselton, D.M., 2011. Evaluation of the Randox whole Blood Drugs of Abuse (DOA) Microchip Arrays for Use With Alternative Postmortem Samples as a Near Body Screen. In: American Academy of Forensic Sciences 21-26 February 2011 Chicago, IL, USA.
  • Reichardt, E.M., Baldwin, D. and Osselton, D.M., 2011. Investigation of the effect of Vinegar on Oral Fluid Drug Testing: Effects on Immunoassay screening. In: American Academy of Forensic Sciences 21-26 February 2011 Chicago, IL, USA.
  • Osselton, D.M., 2011. Driving under the Influence of Drugs. In: Driving under the Influence of Drugs. 18 February 2011 University of Sao Paulo, Department of Forensic Medicine, Sao Paulo, Brazil.
  • McLaughlin, P., Pounder, D., Cox, S. and Osselton, D.M., 2011. Rapid Analysis of Liver, Muscle and Vitreous humor Samples Using the Randox Whole Blood Drugs of abuse (DOA) Arrats for Use as a Near Body Screen During autopsy. In: 2011 Joint Meeting of Society of Forensic Toxicologists(SOFT) & International Association of Forensic Toxicologists (TIAFT) 25-30 September 2011 San Fransisco,CA, USA.
  • de Almeida, R., Leyton, V., Seulin, S., Gianvecchio, V., Osselton, D.M. and Yonamine, M., 2011. Determination of Barbiturates and Postmortem Whole Blood Samples Using Hollow Fibre Liquid Phase Microextraction and GC/MS. In: 2011 Joint Meeting of Society of Forensic Toxicologists(SOFT) & International Association of Forensic Toxicologists (TIAFT) 25-30 September 2011 San Fransisco,CA, USA.
  • Osselton, D.M., 2010. Forensic Toxicology: Past, Present and Future. In: Plenary lecture, Society of Forensic Toxicologists 2010, Richmond Virginia 18-22 October 2010 Richmond, Virginia, UAS.
  • Reichardt, E., Baldwin, D. and Osselton, D.M., 2010. Comparison of the Effects of Different Foods and Drinks on the Orasure "Intercept" and Concatino "Certus" Oral Fluid Collection Devices and Immunoassay screening. In: Society of Forensic Toxicologists Conference 18-22 October 2010 Richmond, Virginia, USA.
  • McLaughlin, P., Pounder, D. and Osselton, D.M., 2010. Evaluation of the Randox Whole Blood Drugs of Abuse Arrays I and II for the analysis of Alternative Postmortem Toxicology Samples. In: Society of Forensic Toxicologists annual Conference 18-22 October 2010 Richmond, Virginia, USA.
  • Reichardt, E., Ramsey, J. and Osselton, D.M., 2010. Purity of Street Ketamine Preparations Retrieved from Night Club Amnesty Bins. In: Society of Forensic Toxicologists Annual Conference 18-22 October 2010 Richmond, Virginia.
  • Bunten, H., Liang, W.-J., Pounder, D. and Osselton, D.M., 2010. Linkage between Methadone Fatality and OPRM1 and CYP2B6 gene variants. In: Society of Forensic Toxicologists 18-22 October 2010 Richmond, Virginia.
  • Osselton, D.M., 2010. What pathologists and Coroners need to understand about toxicology. In: Coronial Death Investigation 18-19 June 2010 Royal Society of Medicine, London.
  • Osselton, D.M., 2009. Factors Affecting the Interpretation of Toxicological Analyses. In: Indelible evidence - The Forensic Science Society 12 December 2009 University of the West of England, Bristol, UK.
  • Osselton, D.M., 2009. Postmortem Toxicology Past, Present and Future. In: 50 years of Forensic Toxicology at the University of Glasgow 26-27 March 2009 Glasgow,Scotland.
  • Osselton, D.M., 2008. Developments in Forensic Toxicology and the Curry Influence. In: London Toxicology Group July 2008 London.
  • Osselton, D.M., 2008. Developments in Forensic Toxicology. In: Egyptian Conference on Forensic Sciences 16-18 April 2008 Ramses Hilton, Cairo, Egypt.
  • Chatterton, C.N. and Osselton, D.M., 2008. Drug Use in UK Drivers: Concentrations of Benzodiazepines and Opioids in Whole Blood Specimens Collected From Drivers Suspected of Driving Whilst Impaired Through Drugs in England and Wales. In: Society of Forensic Toxicologists October 2008 Pheonix, Arizona, USA.
  • Chatterton, C.N. and Osselton, D.M., 2007. Drug Use in UK Drivers:Concentrations of Amfetamine, Methylenedioxymethylanfetamine (MDMA) and Cocaine in Whole Blood Specimens Collected from Drivers Suspected of Driving Whilst Impaired Through Drugs in England and Wales. In: Society of Forensic Toxicologists (SOFT) Annual Meeting 14-19 October 2007 Raleigh-Durham, North Carolina, USA.
  • Osselton, D.M., 2007. Drugs and Driving. In: ABRAMET (Brazilian Association for Road Traffic Safety) September 2007 Puerto Segura, Brazil.
  • Osselton, D.M., 2007. Alcohol and Traffic. In: Brazilian Police Conference on Traffic Policing September 2007 Sao Paulo, Brazil.

Reports

PhD Students

  • Stephen Ambore (Cybersecurity for the Unbanked)
  • Kelly Ann Rees (The Distribution of Opiates, Cocaine and their Metabolites in skeletal Muscle Tissue and Vitreous Humour as and Aid to Post-mortem Toxicological Interpretation)
  • Andrew Postles (Factors affecting the measurement of Safety and Stability of Cosmetic Products)
  • Aida Merchan (Invsetigating the distribution of Cocaine and Herion in Oral Tissues)
  • David Charlton (An Industrial Revolution for Fingerprint science? The Impact of Cognition and Human Factors on Fingerprint examiners: Implications for the Use of Fingerprint Examiner expertise and Administration within Law enforcement)
  • Hannah Bunten (Exploring the role of mu opioid receptor (OPRM1) and CYP2B6 gene variations for methadone pharmacogenomics. Can variations be used to advance toxicological interpretation post-mortem?)
  • Sarah Lockyer (nterpersonal violence and fracture patterns in 18th- and 19th-century London)
  • Marie-Christine Dussault (Blast injury to the human skeleton: Identification and differentiation using statistical approaches)
  • Poppy McLaughlin (Pharmacogenomics of Morphine in Cancer Patients)
  • Eva Reichardt (Investigation of Drug Depots in Oral Fluid)

Profile of Teaching PG

  • Extended Research Project - Toxicology
  • Labroatory and Research Skills
  • Forensic Toxicology

Profile of Teaching UG

  • Forensic Science
  • Forensic Toxicology
  • Introduction to Toxicology
  • Advanced Forensic Science

Invited Lectures

  • Lecture to the Clinical Forensic Medicine Section at the Royal Society of Medicine conference on Novel Psychoactive substances
  • Post mortem Vitrectomy - Review of the use of Vitreous Humour in Forensic Toxicology. Given to the 101 Oxford Opthalmological Conference in Oxford
  • Tackling the Challenges of Drugs in Society, Conference: "Partnerships in Safety; Building Safe and Just Societies’, Titanic Centre, Belfast
  • Recent Developments relating to driving under the infleunce of drugs and roadside drug testing, Royal Society of Medicine, London
  • Keynote Lecture, Driving under the Influence of Drugs, 50th Anniversary Meeting of the International Assoiation of Forensic Toxicologists, Barbican, London, 26-27 April, 2013.
  • Challenges in Interpreting Toxicology Results, International Clarke Conference on Analytical Toxicology, Royal Pharmaceutical Society, London, 25 May 2011.
  • Challenges with Interpretation in Forensic Toxicology, 3rd Egyptian Intl Conference of Medical & Forensic Sciences, 16-18th April 2008, Cairo.
  • What Pathologists and Coroners Need to Know about Forensic Toxicology, Royal society of Medicine,London,Meeting on CoronialDeath Incestigation, 19 June, 2010
  • Forensic Toxicology: Past, Present and Future, XVII Brazilian Congress of Toxicology, Ribeirao Preto, Brazil, 22-25 June 2011.
  • Pharmacogenomics Applied to Forensic Sciences, XVII Brazilian Congress of Toxicology, Ribeirao Preto, Brazil, 22025 June 2011
  • Interpretation in Forensic Toxicology, 1st Saudi International Conference for Forensic Medical Sciences, Riyadh, 11th-14t March 2012

Conference Presentations

  • Novel Psychoactive substances, Synthetic Cannabinoids and Fentanyls, 16 June 2017, Royal society of Medicine, London
  • Oxford Ophthalmological Conference, Post mortem Vitrectomy, 3 July 2017, Oxford

Qualifications

  • SFHEA in Eduaction (Higher Education Academy, 2016)
  • Fellow of the Royal society of Chemistry in Chemistry (Royal Society of Chemistry, 1985)
  • Chartered Chemist in Chemistry (Royal society of Chemistry, 1985)
  • Chartered Scientist in Chemistry (Royal Society of Chemistry, 2004)
  • PhD in Biochemistry (London University, 1974)
  • BSc (Hons) in Biochemistry (London University, 1971)

Memberships

  • Chartered Society of Forensic Sciences, Fellow (2012-),
  • International Associatio of Forensic Toxicologists, Member (1975-), http://www.tiaft/
  • LTG (formely London Toxicology Group), Member,
  • Royal society of Biology, Fellow (2013-),
  • Royal society of Chemistry, Fellow,
  • Society of Forensic Toxicologists (SOFT), Member,
  • United Kingdom and Ireland Association of Forensic Toxicologists (UKIAFT), Chair,
The data on this page was last updated at 04:07 on September 19, 2017.